PALM BEACH, Florida, June 26, 2019 /PRNewswire/ --
A recent article in the Green Fund said that: "The global cannabis market is thought to be worth USD$150 billion today (March 15, 2019). Barclays, in their European Consumer Staples Report in September 2018, suggests that this figure could increase to USD$272 billion by 2028." Every day more articles and new revenue projection are released opining on what has happened and are replete with newer and higher projections. Inside his tsunami of information one common thread becomes obvious. The market will rise in 2019. There will be more product, more revenues, more infrastructure, more projections and more news. Active companies in the market today includes: Relevium Technologies Inc . (TSX-V: RLV) (OTCQB: RLLVF), PharmaCielo Ltd. (TSX-V: PCLO) (OTCPK: PHCEF), Khiron Life Sciences Corp. (TSX-V: KHRN.V) (OTCQB: KHRNF), Sorrento Therapeutics, Inc. (NASDAQ: SRNE), Liberty Health Sciences Inc. (CSE: LHS.CN) (OTCQX: LHSIF).
One of the key sub-markets will be the expansion of the cultivation & extraction business operations. As the medicinal markets grow, there needs to be supervision at every level in the growth, cultivation and extraction operations. Many companies will look to Latin America to add these operations to their vertical marketing operations. Why Latin America? Because, the Green Fund says : "... the region is known for almost perfect growing conditions, and when coupled with large amounts of available farming land, very low costs of labor, sunshine that can drive up to two harvests per annum, and the booming home grow culture mentioned above, you have a region primed to potentially become the global leader's in low-cost cannabis production…." The region boasts exceptional climatic conditions, with lots of sunshine and good rainfall. This coupled with acres and acres of arable land, could make the LATAM region the global leaders in cannabis production.
